Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Ono and Domain Therapeutics enter GPCR collaboration

Oct. 23, 2012

Astellas and AIST to collaborate on discovering drugs for neglected tropical diseases

Oct. 22, 2012

Pfenex receives NIH contract to develop dry formulation of rPA-based anthrax vaccine

Oct. 19, 2012

Prolor Biotech reports preclinical RPeg toxicology data

Oct. 18, 2012

Oncodesign and Sanofi enter kinase research collaboration

Sep. 17, 2012

Critical Outcome Technologies and Delmar Chemicals sign R&D collaboration

Sep. 14, 2012

Visterra and Pfizer to collaborate on novel antibody discovery

Sep. 13, 2012

Bristol-Myers licenses Summit's Seglin drug discovery platform

Sep. 12, 2012

New models designed to predict drug toxicity for liver and kidney

Aug. 28, 2012

Industry spotlight: Orphan drug R&D is a viable biopharma strategy

Aug. 23, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...